ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2026
Individual-Level Trends in Mammography Screening over 14 years: Results from an All-Payer Statewide Claims Database.
Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundOur objective was to characterize individual-level screening patterns during a fourteen-year period spanning changing breast cancer screening guidelines and the COVID-19 pandemic.
methodsWe conducted a retrospective analysis of mammography screening in women ages 40 years and older using 2010 to 2023 data from the Vermont Health Care Uniform Reporting and Evaluation System, a statewide all-payer insurance claims database.
resultsBiennial mammography screening adherence declined between 2010 to 2023 by 20.7 and 6.7 percentage points for women ages 40 to 49 and 50 to 74 years, respectively. Younger birth cohorts consistently had lower screening rates at any given age compared with older cohorts. Cohorts under age 50 years during the COVID-19 pandemic have had the largest postpandemic recoveries, with postpandemic screening rates exceeding prepandemic screening adherence.
conclusionsWhereas mammography screening rates have been declining both between and within birth cohorts, pandemic disruptions have narrowed the gaps resulting from these trends. IMPACT: Sustaining postpandemic screening momentum may be critical to reversing long-term declines in adherence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.